{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:07:39Z","timestamp":1789474059945,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:00:00Z","timestamp":1787443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007414","name":"Qassim University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-68038-z","type":"journal-article","created":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T12:43:35Z","timestamp":1787489015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and comparative evaluation of in vitro, ex vivo, and in vivo models for the assessment of broad-spectrum topical antimicrobial efficacy"],"prefix":"10.1038","volume":"16","author":[{"given":"Faris S.","family":"Alnezary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaad Saeed","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,23]]},"reference":[{"issue":"1","key":"68038_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/1471-2334-13-252","volume":"13","author":"GT Ray","year":"2013","unstructured":"Ray, G. T., Suaya, J. A. & Baxter, R. Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a US population: a retrospective population-based study. BMC Infect. Dis. 13 (1), 252 (2013).","journal-title":"BMC Infect. Dis."},{"issue":"Supplement_3","key":"68038_CR2","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1093\/cid\/ciz002","volume":"68","author":"KS Kaye","year":"2019","unstructured":"Kaye, K. S. et al. Current epidemiology, etiology, and burden of acute skin infections in the United States. Clin. Infect. Dis. 68(Supplement_3), S193\u2013S199 (2019).","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"68038_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3390\/antibiotics12030557","volume":"12","author":"MS Linz","year":"2023","unstructured":"Linz, M. S. et al. Clinical impact of Staphylococcus aureus skin and soft tissue infections. Antibiotics 12 (3), 557 (2023).","journal-title":"Antibiotics"},{"key":"68038_CR4","doi-asserted-by":"publisher","first-page":"fuaf058","DOI":"10.1093\/femsre\/fuaf058","volume":"49","author":"G Arcari","year":"2025","unstructured":"Arcari, G. et al. Global spread of Streptococcus pyogenes A genomics-supported narrative review. FEMS Microbiol. Rev. 49, fuaf058. https:\/\/doi.org\/10.1093\/femsre\/fuaf058 (2025).","journal-title":"FEMS Microbiol. Rev."},{"issue":"2","key":"68038_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4266\/acc.2023.01571","volume":"39","author":"S Roy","year":"2024","unstructured":"Roy, S. et al. Microbial infections in burn patients. Acute Crit. Care. 39 (2), 214\u2013225 (2024).","journal-title":"Acute Crit. Care"},{"issue":"34","key":"68038_CR6","doi-asserted-by":"publisher","first-page":"e30120","DOI":"10.1097\/md.0000000000030120","volume":"101","author":"H Li","year":"2022","unstructured":"Li, H. et al. Efficacy and safety of optional parenteral antimicrobial therapy for complicated skin and soft tissue infections: A systematic review and Bayesian network meta-analysis. Medicine, 101(34),  e30120. https:\/\/doi.org\/10.1097\/md.0000000000030120 (2022).","journal-title":"Medicine"},{"key":"68038_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/cid\/cix754","volume":"66","author":"P Hogan","year":"2018","unstructured":"Hogan, P. et al. Impact of Systemic Antibiotics on Staphylococcus aureus Colonization and Recurrent Skin Infection. Clin. Infect. Dis. 66, 191 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"68038_CR8","unstructured":"Westgeest, A. et al. Eradication of community-onset MRSA carriage: a narrative review. Clinical microbiology and infection: the official publication of the European Society (of Clinical Microbiology and Infectious Diseases, 2024)."},{"key":"68038_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1128\/CMR.00049-15","volume":"29","author":"E Septimus","year":"2016","unstructured":"Septimus, E. & Schweizer, M. Decolonization in Prevention of Health Care-Associated Infections. Clin. Microbiol. Rev. 29, 201\u2013222 (2016).","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"68038_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4103\/0974-2727.163127","volume":"7","author":"MS Rudresh","year":"2015","unstructured":"Rudresh, M. S. et al. Prevalence of Mupirocin Resistance Among Staphylococci, its Clinical Significance and Relationship to Clinical Use. J. Lab. Physicians. 7 (2), 103\u2013107 (2015).","journal-title":"J. Lab. Physicians"},{"issue":"1","key":"68038_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/jac\/41.1.11","volume":"41","author":"BD Cookson","year":"1998","unstructured":"Cookson, B. D. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J. Antimicrob. Chemother. 41 (1), 11\u201318 (1998).","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"68038_CR12","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1086\/605495","volume":"49","author":"J Patel","year":"2009","unstructured":"Patel, J., Gorwitz, R. & Jernigan, J. Mupirocin resistance. Clin. Infect. diseases: official publication Infect. Dis. Soc. Am. 49 (6), 935\u2013941 (2009).","journal-title":"Clin. Infect. diseases: official publication Infect. Dis. Soc. Am."},{"key":"68038_CR13","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.biopha.2018.10.131","volume":"109","author":"S Khoshnood","year":"2019","unstructured":"Khoshnood, S. et al. A review on mechanism of action, resistance, synergism, and clinical implications of mupirocin against Staphylococcus aureus. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 109, 1809\u20131818 (2019).","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"5","key":"68038_CR14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1086\/520663","volume":"45","author":"JC Jones","year":"2007","unstructured":"Jones, J. C. et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin. Infect. Dis. 45 (5), 541\u2013547 (2007).","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"68038_CR15","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1128\/JCM.00302-12","volume":"50","author":"E Bathoorn","year":"2012","unstructured":"Bathoorn, E. et al. Emergence of high-level mupirocin resistance in coagulase-negative staphylococci associated with increased short-term mupirocin use. J. Clin. Microbiol. 50 (9), 2947\u20132950 (2012).","journal-title":"J. Clin. Microbiol."},{"issue":"12","key":"68038_CR16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1086\/647243","volume":"17","author":"KR Netto dos Santos","year":"1996","unstructured":"Netto dos Santos, K. R., de Souza Fonseca, L. & Gontijo Filho, P. P. Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian university hospitals. Infect. Control Hosp. Epidemiol. 17(12), 813\u20136 (1996).","journal-title":"Infect. Control Hosp. Epidemiol."},{"issue":"6","key":"68038_CR17","doi-asserted-by":"publisher","first-page":"414","DOI":"10.46747\/cfp.6706414","volume":"67","author":"C Choi","year":"2021","unstructured":"Choi, C. et al. Approach to allergic contact dermatitis caused by topical medicaments. Can. Fam Physician. 67 (6), 414\u2013419 (2021).","journal-title":"Can. Fam Physician"},{"key":"68038_CR18","first-page":"521","volume":"30","author":"S Jacob","year":"2004","unstructured":"Jacob, S. & James, W. From Road Rash to Top Allergen in a Flash: Bacitracin. Dermatol. Surg. 30, 521 (2004).","journal-title":"Dermatol. Surg."},{"key":"68038_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.12.029","author":"R Sidbury","year":"2023","unstructured":"Sidbury, R. et al. Guidelines of care for the management of atopic dermatitis in adults with topical therapies. J. Am. Acad. Dermatol. https:\/\/doi.org\/10.1016\/j.jaad.2022.12.029 (2023).","journal-title":"J. Am. Acad. Dermatol."},{"key":"68038_CR20","doi-asserted-by":"crossref","unstructured":"McBain, A. J. Chap. 4: In vitro biofilm models: an overview. Adv Appl Microbiol, 69: pp. 99\u2013132. (2009).","DOI":"10.1016\/S0065-2164(09)69004-3"},{"issue":"3","key":"68038_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00004630-198905000-00003","volume":"10","author":"IA Holder","year":"1989","unstructured":"Holder, I. A. The wet disc antimicrobial solution assay. An in vitro method to test efficacy of antimicrobial solutions for topical use. J. Burn Care Rehabil. 10(3), 203\u20138 (1989).","journal-title":"J. Burn Care Rehabil."},{"key":"68038_CR22","doi-asserted-by":"publisher","first-page":"e00024","DOI":"10.1128\/cmr.00024-23","volume":"36","author":"T Coenye","year":"2023","unstructured":"Coenye, T. Biofilm antimicrobial susceptibility testing: Where are we and where could we be going?. Clin. Microbiol. Rev. 36, e00024\u201323. https:\/\/doi.org\/10.1128\/cmr.00024-23 (2023).","journal-title":"Clin. Microbiol. Rev."},{"issue":"10","key":"68038_CR23","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/1469-0691.12651","volume":"20","author":"M Maci\u00e0","year":"2014","unstructured":"Maci\u00e0, M., Rojo-Molinero, E. & Oliver, A. Antimicrobial susceptibility testing in biofilm-growing bacteria. Clin. Microbiol. Infect. 20(10), 981\u2013990 (2014).","journal-title":"Clin. Microbiol. Infect."},{"key":"68038_CR24","doi-asserted-by":"crossref","unstructured":"Smoot, E. C. 3rd. et al. Susceptibility testing of topical antibacterials against methicillin-resistant Staphylococcus aureus. J. Burn Care Rehabil. 13(2 Pt 1), 198\u2013202 (1992).","DOI":"10.1097\/00004630-199203000-00004"},{"issue":"2","key":"68038_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.burns.2010.09.017","volume":"37","author":"AA Hammond","year":"2011","unstructured":"Hammond, A. A. et al. An in vitro biofilm model to examine the effect of antibiotic ointments on biofilms produced by burn wound bacterial isolates. Burns 37 (2), 312\u2013321 (2011).","journal-title":"Burns"},{"issue":"1","key":"68038_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.burns.2009.02.017","volume":"36","author":"P Kennedy","year":"2010","unstructured":"Kennedy, P., Brammah, S. & Wills, E. Burns, biofilm and a new appraisal of burn wound sepsis. Burns 36 (1), 49\u201356 (2010).","journal-title":"Burns"},{"issue":"8","key":"68038_CR27","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1007\/s11095-006-9011-8","volume":"23","author":"C Herkenne","year":"2006","unstructured":"Herkenne, C. et al. Pig ear skin ex vivo as a model for in vivo dermatopharmacokinetic studies in man. Pharm. Res. 23 (8), 1850\u20131856 (2006).","journal-title":"Pharm. Res."},{"key":"68038_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00998","volume":"11","author":"E Maslova","year":"2020","unstructured":"Maslova, E. et al. An invertebrate burn wound model that recapitulates the hallmarks of burn trauma and infection seen in mammalian models. Front. Microbiol. 11, 998 (2020).","journal-title":"Front. Microbiol."},{"key":"68038_CR29","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ijbiomac.2020.04.235","volume":"158","author":"GQ Fu","year":"2020","unstructured":"Fu, G. Q. et al. Xylan-based hydrogels for potential skin care application. Int. J. Biol. Macromol. 158, 244\u2013250 (2020).","journal-title":"Int. J. Biol. Macromol."},{"key":"68038_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1590\/S1517-83822007000200034","volume":"38","author":"C Valgas","year":"2007","unstructured":"Valgas, C. et al. Screening methods to determine antibacterial activity of natural products. Brazilian J. Microbiol. 38, 369\u2013380 (2007).","journal-title":"Brazilian J. Microbiol."},{"issue":"1\u20132","key":"68038_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0378-5173(00)00665-7","volume":"215","author":"FP Schmook","year":"2001","unstructured":"Schmook, F. P., Meingassner, J. G. & Billich, A. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int. J. Pharm. 215(1\u20132), 51\u20136 (2001).","journal-title":"Int. J. Pharm."},{"issue":"3","key":"68038_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1128\/jcm.24.3.343-348.1986","volume":"24","author":"LW Bush","year":"1986","unstructured":"Bush, L. W., Benson, L. M. & White, J. H. Pig skin as test substrate for evaluating topical antimicrobial activity. J. Clin. Microbiol. 24 (3), 343\u2013348 (1986).","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"68038_CR33","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/21505594.2015.1135289","volume":"7","author":"CJ Tsai","year":"2016","unstructured":"Tsai, C. J., Loh, J. M. & Proft, T. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence 7 (3), 214\u2013229 (2016).","journal-title":"Virulence"},{"issue":"6","key":"68038_CR34","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1128\/AAC.01533-08","volume":"53","author":"AY Peleg","year":"2009","unstructured":"Peleg, A. Y. et al. Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob. Agents Chemother. 53 (6), 2605\u20132609 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"68038_CR35","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41579-018-0048-6","volume":"16","author":"D Du","year":"2018","unstructured":"Du, D. et al. Multidrug efflux pumps: structure, function and regulation. Nat. Rev. Microbiol. 16, 523\u2013539 (2018).","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"68038_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13613-015-0061-0","volume":"5","author":"E Rupp\u00e9","year":"2015","unstructured":"Rupp\u00e9, E., Woerther, P. & Barbier, F. Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann. Intensive Care, 5(1), 61. https:\/\/doi.org\/10.1186\/s13613-015-0061-0 (2015).","journal-title":"Ann. Intensive Care"},{"issue":"8","key":"68038_CR37","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/iub.1289","volume":"66","author":"J Fishovitz","year":"2014","unstructured":"Fishovitz, J. et al. Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. IUBMB Life. 66 (8), 572\u2013577 (2014).","journal-title":"IUBMB Life"},{"issue":"1","key":"68038_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrmicro3380","volume":"13","author":"JM Blair","year":"2015","unstructured":"Blair, J. M. et al. Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol. 13(1), 42\u201351 (2015).","journal-title":"Nat. Rev. Microbiol."},{"issue":"4","key":"68038_CR39","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/pharmaceutics17040503","volume":"17","author":"AH Kimura","year":"2025","unstructured":"Kimura, A. H. et al. Hydrogel Containing Biogenic Silver Nanoparticles and Origanum vulgare Essential Oil for Burn Wounds: Antimicrobial Efficacy Using Ex Vivo and In Vivo Methods Against Multidrug-Resistant Microorganisms. Pharmaceutics 17 (4), 503 (2025).","journal-title":"Pharmaceutics"},{"issue":"11 Suppl","key":"68038_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.12968\/bjcn.2003.8.Sup5.12607","volume":"8","author":"K Vowden","year":"2003","unstructured":"Vowden, K. & Vowden, P. Understanding exudate management and the role of exudate in the healing process. Br. J. Community Nurs. 8 (11 Suppl), 4\u201313 (2003).","journal-title":"Br. J. Community Nurs."},{"issue":"8","key":"68038_CR41","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3390\/pharmaceutics17081039","volume":"17","author":"D M\u00fcller","year":"2025","unstructured":"M\u00fcller, D., Nallbati, L. & Keck, C. Smart-AMPs: Decorated nanostructured lipid carriers for improved efficacy of antimicrobial peptides in chronically infected burn wounds. Pharmaceutics, 17(8), 1039. https:\/\/doi.org\/10.3390\/pharmaceutics17081039 (2025).","journal-title":"Pharmaceutics"},{"issue":"9","key":"68038_CR42","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.3390\/ijms22095045","volume":"22","author":"M Andersson","year":"2021","unstructured":"Andersson, M. et al. Development of an experimental ex vivo wound model to evaluate antimicrobial efficacy of topical formulations. Int. J. Mol. Sci. 22(9), 5045 https:\/\/doi.org\/10.3390\/ijms22095045 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"68038_CR43","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1111\/jam.15756","volume":"133","author":"Y Cheng","year":"2022","unstructured":"Cheng, Y., De Bank, P. A. & Bolhuis, A. An in vitro and ex vivo wound infection model to test topical and systemic treatment with antibiotics. J. Appl. Microbiol. 133 (5), 2993\u20133006 (2022).","journal-title":"J. Appl. Microbiol."},{"issue":"2","key":"68038_CR44","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/wrr.12890","volume":"29","author":"BA Pati","year":"2021","unstructured":"Pati, B. A. et al. Antibiofilm activity of chitosan\/epsilon-poly-L-lysine hydrogels in a porcine ex vivo skin wound polymicrobial biofilm model. Wound Repair Regen. 29(2), 316\u2013326 (2021).","journal-title":"Wound Repair Regen."},{"key":"68038_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00174","volume":"9","author":"J H\u00e5kansson","year":"2019","unstructured":"H\u00e5kansson, J. et al. Characterization of the in vitro, ex vivo, and in vivo efficacy of the antimicrobial peptide DPK-060 used for topical treatment. Front. Cell. Infect. Microbiol. 9, 174 (2019).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"13","key":"68038_CR46","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1128\/JB.182.13.3843-3845.2000","volume":"182","author":"G Jander","year":"2000","unstructured":"Jander, G., Rahme, L. G. & Ausubel, F. M. Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects. J. Bacteriol. 182(13), 3843\u20135 (2000).","journal-title":"J. Bacteriol."},{"key":"68038_CR47","first-page":"163","volume":"8","author":"E Abd","year":"2016","unstructured":"Abd, E. et al. Skin models for the testing of transdermal drugs. Clin. Pharmacol. 8, 163\u2013176 (2016).","journal-title":"Clin. Pharmacol."},{"issue":"1","key":"68038_CR48","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.femsre.2003.09.002","volume":"28","author":"K Kavanagh","year":"2004","unstructured":"Kavanagh, K. & Reeves, E. P. Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens. FEMS Microbiol. Rev. 28 (1), 101\u2013112 (2004).","journal-title":"FEMS Microbiol. Rev."},{"issue":"6","key":"68038_CR49","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/jac\/dkn125","volume":"61","author":"G M\u00fcller","year":"2008","unstructured":"M\u00fcller, G. & Kramer, A. Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J. Antimicrob. Chemother. 61 (6), 1281\u20131287 (2008).","journal-title":"J. Antimicrob. Chemother."},{"issue":"9","key":"68038_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00441-25","volume":"10","author":"EC Townsend","year":"2025","unstructured":"Townsend, E. C. et al. Establishing an ex vivo porcine skin model to investigate the effects of broad-spectrum antiseptic on viable skin microbial communities. mSphere 10(9), e0044125 (2025).","journal-title":"mSphere"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-68038-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-68038-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-68038-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:52:02Z","timestamp":1789473122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-68038-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,23]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68038"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-68038-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,23]]},"assertion":[{"value":"11 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28732"}}